Missense Variant in MAPK Inactivator <i>PTPN5</i> Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring by Ravi F. Sood (263139)

“…</p><p>Results</p><p>Our study population consisted of 538 adults (median age 40 years) who were predominantly White (76%) males (71%) admitted to our center from 2007–2014 with small-to-moderate-sized burns (median burn size 6% total body surface area). Of 2,146 SNPs tested, a rare missense variant in the <i>PTPN5</i> gene (rs56234898; minor allele frequency 1.5%) was significantly associated with decreased severity of post-burn HTS (<i>P</i> = 1.3×10⁻⁶). …”

Glucose decreases the ability of HNF4α to activate the transcription of the <i>NR2F2</i> proximal promoter and to bind its chromatin target. by Marie Boutant (164748)

Panel probit models: Dummy variable which takes a value of 1 for a top 5 publication. by Sergey V. Popov (6719075)

Theme 5 results—mortality. by Corey J. A. Bradshaw (8032406)

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

Subjects:

Mutant TRIT1 has decreased <i>in vitro</i> activity and cannot complement <i>tit1</i>-Δ defects in <i>S. pombe</i>. by John W. Yarham (573109)

Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

“…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”

<i>Fgfr2^+/S252W</i> mice had shortened bone length and decreased bone mass compared with wild-type mice. by Peng Chen (6514)

“…<p>(A–F) X-ray analyses of femora, tibia and lumbar vertebrae from WT and MT mice at P5 (A, B), P10 (C, D) and P28 (E, F) revealed shorter bone length and lower bone density in mutant mice. …”

Data for Figs 1A–1I, 2A–2J, 3B–3H, 4A–4L, 5A–5C, 6A–6C, 6E, by Xiaohua Zhang (350570)

<i>Il6</i>-KO decreases hypothalamic <i>Il6ra</i> mRNA content in early, mid but not in late pregnant mice. by Patricia Pazos (451138)

Schematic illustration of the prediction model for all the five vignettes. by Michelle Dey (525235)

Real-time measurements of cAMP in response to IBMX in control and AICAR-treated rat AVMs. by Anne Garnier (130125)

Subjects:

A+N_pFL does not affect breathing. by Robert T. R. Huckstepp (3391586)

Response of developed pressure to forskolin and isoprenaline of isolated perfused hearts. by Anne Garnier (130125)

Subjects:

Fold change with steady state myocardial mRNA levels for components of the inflammasome. by Stephanie L. Samani (17896610)

Co-localization of LysoTracker and Mtb-phagosomes is decreased by <i>H</i>. <i>diminuta</i> and <i>T</i>. <i>muris</i> antigen treatment. by Naomi Aira (3743911)

Fig 1 - by Stephanie L. Samani (17896610)

S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model by Tae-Young Ha (254769)

Supplementary Material for: MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation by Su F. (4127968)

BrdU-positive mossy cell precursors are decreased in the hilus of developing Rac1^N/Rac3^KO mice. by Roberta Pennucci (83950)